IL6 and metabolic dysfunction-associated steatotic liver disease: Visceral WAT was independently associated with hepatic inflammation and fibrosis in NAFLD subjects and serum IL-6 levels, which correlated with visceral fat, independently predicting an increase in hepatic inflammation [1].